Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate-severe Glabellar Lines”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT05804656
What this trial is testing

Efficacy and Safety of CKDB-501A in Subjects With Moderate-to-severe Glabellar Lines in Phase 3 Trial

Who this might be right for
Glabellar Lines
CKD Bio Corporation 300
Testing effectiveness (Phase 2)Study completedNCT03806933
What this trial is testing

Study to Investigate the Safety and Duration of Effect of Different Botulinum Toxin A (NT 201) Dose Groups Following the Treatment of Glabellar Frown Lines

Who this might be right for
Moderate to Severe Glabellar Frown Lines
Merz Aesthetics GmbH 241
Large-scale testing (Phase 3)Study completedNCT07622004
What this trial is testing

Evaluate the Efficacy and Safety of INI101 Compared to BOTOX® in Subjects With Moderate to Severe Glabellar Lines.

Who this might be right for
Glabellar Lines
INIBIO Co., Ltd. 292
Early research (Phase 1)Study completedNCT04944953
What this trial is testing

To Compare the Safety and Efficacy of "HG-102" With Botox® in the Improvement of Moderate to Severe Glabellar Lines.

Who this might be right for
Glabellar Lines
Hugel 38
Large-scale testing (Phase 3)Not Yet RecruitingNCT07013279
What this trial is testing

Evaluate the Efficacy and Safety of DWP712 With Moderate to Severe Glabellar Lines

Who this might be right for
Glabellar Lines
Daewoong Pharmaceutical Co. LTD. 324
Post-approval studies (Phase 4)Study completedNCT03687736
What this trial is testing

Subject Satisfaction With AbobutulinumtoxinA Treatment

Who this might be right for
Glabellar Frown Lines
Galderma R&D 120
Large-scale testing (Phase 3)Study completedNCT05059587
What this trial is testing

Study to Evaluate the Efficacy and Safety of MBA-P01 in Subjects With Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Medytox Korea 318
Large-scale testing (Phase 3)Study completedNCT04594213
What this trial is testing

Safety and Efficacy Study of the Simultaneous Treatment of Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines and Lateral Canthal Lines) in Subjects With Moderate to Severe Upper Facial Lines

Who this might be right for
Moderate to Severe Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines, and Lateral Canthal Lines)
Merz North America, Inc. 362
Testing effectiveness (Phase 2)Study completedNCT05743634
What this trial is testing

A Phase I/II Study of Recombinant Botulinum Toxin Type A for the Treatment of Moderate to Severe Glabellar Lines

Who this might be right for
Moderate to Severe Glabellar Lines
Chongqing Claruvis Pharmaceutical Co., Ltd. 140
Large-scale testing (Phase 3)Study completedNCT03014635
What this trial is testing

Efficacy and Safety of DaxibotulinumtoxinA for Injection to Treat Moderate to Severe Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Revance Therapeutics, Inc. 306
Large-scale testing (Phase 3)Study completedNCT05321979
What this trial is testing

Long-term Extension Study to Evaluate MBA-P01 in Subjects With Moderate to Severe Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Medytox Korea 253
Large-scale testing (Phase 3)Study completedNCT04622254
What this trial is testing

Safety and Efficacy Study of the Simultaneous Treatment of Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines and Crows Feet) in Subjects With Moderate to Severe Upper Facial Lines

Who this might be right for
Moderate to Severe Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines, and Lateral Canthal Lines)
Merz North America, Inc. 368
Large-scale testing (Phase 3)Study completedNCT06124794
What this trial is testing

The Efficacy and Safety of Protoxin in Subjects With Moderate to Severe Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Protox Inc. 155
Post-approval studies (Phase 4)Study completedNCT02568150
What this trial is testing

Evaluation Onset Time of DWP450-004 and Safety in Moderate-severe Glabellar Lines

Who this might be right for
Moderate-severe Glabellar Lines
Daewoong Pharmaceutical Co. LTD. 45
Large-scale testing (Phase 3)Study completedNCT06308198
What this trial is testing

Evaluate AGN-151586 Intramuscular Injections in Adult Participants for Treatment of Glabellar Lines

Who this might be right for
Glabellar Lines
AbbVie 161
Large-scale testing (Phase 3)Study completedNCT02334436
What this trial is testing

A Phase III Study to Demonstrate the Safety and Efficacy of DWP-450 to Treat Glabellar Lines - EV-002

Who this might be right for
Glabellar Frown Lines
Evolus, Inc. 324
Large-scale testing (Phase 3)Study completedNCT04830345
What this trial is testing

Efficacy and Safety of Botulinum Toxin at Moderate to Severe Glabellar Lines

Who this might be right for
Glabellar Frown Lines
EuBiologics Co.,Ltd 290
Large-scale testing (Phase 3)Study completedNCT05148000
What this trial is testing

Assess Aesthetic Improvement With QM1114-DP in Subjects With Moderate to Severe Lateral Canthal Lines and Glabellar Lines

Who this might be right for
Glabellar Frown LinesCanthal Lines
Galderma R&D 25
Testing effectiveness (Phase 2)Study completedNCT04996810
What this trial is testing

The Safety and Efficacy Study of PROTOXIN in Subjects With Moderate to Severe Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Protox Inc. 60
Large-scale testing (Phase 3)Study completedNCT06583486
What this trial is testing

A Study on the Efficacy and Safety of Repeated Treatments With Recombinant Botulinum Toxin Type A for Injection in the Treatment of Moderate to Severe Glabellar Lines

Who this might be right for
Moderate to Severe Glabellar Lines
Chongqing Claruvis Pharmaceutical Co., Ltd. 488
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation